litlas
ログインアカウント作成

Marion Subklewe

1997–2026 年に発表

163
論文数
18,306
被引用数
67
h 指数
148
i10 指数

被引用数

Marion Subklewe の年別被引用数1990 年: 被引用 1 件1997 年: 被引用 1 件1998 年: 被引用 2 件1999 年: 被引用 26 件2000 年: 被引用 68 件2001 年: 被引用 77 件2002 年: 被引用 63 件2003 年: 被引用 49 件2004 年: 被引用 46 件2005 年: 被引用 38 件2006 年: 被引用 26 件2007 年: 被引用 21 件2008 年: 被引用 19 件2009 年: 被引用 9 件2010 年: 被引用 23 件2011 年: 被引用 6 件2012 年: 被引用 13 件2013 年: 被引用 12 件2014 年: 被引用 31 件2015 年: 被引用 46 件2016 年: 被引用 59 件2017 年: 被引用 70 件2018 年: 被引用 125 件2019 年: 被引用 354 件2020 年: 被引用 708 件2021 年: 被引用 787 件2022 年: 被引用 942 件2023 年: 被引用 1,054 件2024 年: 被引用 1,823 件2025 年: 被引用 1,122 件2026 年: 被引用 37 件1991〜1996 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,469 件、この内訳の 26%中国: 引用元論文 1,183 件、この内訳の 12.4%ドイツ: 引用元論文 887 件、この内訳の 9.3%イギリス: 引用元論文 562 件、この内訳の 5.9%イタリア: 引用元論文 454 件、この内訳の 4.8%フランス: 引用元論文 431 件、この内訳の 4.5%スペイン: 引用元論文 320 件、この内訳の 3.4%オーストラリア: 引用元論文 265 件、この内訳の 2.8%オランダ: 引用元論文 241 件、この内訳の 2.5%スイス: 引用元論文 239 件、この内訳の 2.5%カナダ: 引用元論文 237 件、この内訳の 2.5%日本: 引用元論文 180 件、この内訳の 1.9%
0%26%その他 21.5%

機関

分野

  • Medicine65.5%
  • Immunology and Microbiology17.4%
  • Biochemistry, Genetics and Molecular Biology13.7%
  • Engineering1.1%
  • Neuroscience0.5%
  • Computer Science0.3%
  • その他1.5%

トピック

  • CAR-T cell therapy research12.2%
  • Immune Cell Function and Interaction5.2%
  • Acute Myeloid Leukemia Research5.2%
  • Immunotherapy and Immune Responses5.2%
  • Cancer Immunotherapy and Biomarkers3.1%
  • Virus-based gene therapy research2.7%
  • その他66.4%

共著者

全論文

検索で開く
  1. Cytokine release syndrome

    著者: Alexander Shimabukuro‐Vornhagen, Philipp Gödel, Marion Subklewe, Hans‐Joachim Stemmler, Hans Schlößer, Max Schlaak, Matthias Kochanek, Boris Böll, Michael S. von Bergwelt‐Baildon - Journal for ImmunoTherapy of Cancer 2018 被引用: 1,666

  2. KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study

    著者: Bijal Shah, Armin Ghobadi, Olalekan O. Oluwole, Aaron C. Logan, Nicolas Boissel, Ryan D. Cassaday, Thibaut Leguay, Michael R. Bishop, Max S. Topp, Dimitrios Tzachanis, Kristen M. O’Dwyer, Martha Arellano, Yi Lin, Maria R. Baer, Gary J. Schiller, Jae H. Park, Marion Subklewe, Mehrdad Abedi, Monique C. Minnema, William G. Wierda, Daniel J. DeAngelo, Patrick J. Stiff, Deepa Jeyakumar, Chaoling Feng, Jinghui Dong, Tong Shen, Francesca Milletti, John M. Rossi, Remus Vezan, Behzad Kharabi Masouleh, Roch Houot - The Lancet 2021 被引用: 769

  3. 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

    著者: Michael Heuser, Sylvie Freeman, Gert J. Ossenkoppele, Francesco Buccisano, Christopher S. Hourigan, Lok Lam Ngai, Jesse M. Tettero, Costa Bachas, Constance Baer, Marie C. Béné, Veit Bücklein, Anna Czyż, Barbara Denys, Richard Dillon, Michaela Feuring‐Buske, Mónica L. Guzmán, Torsten Haferlach, Lina Han, Julia Herzig, Jeffrey L. Jorgensen, Wolfgang Kern, Marina Konopleva, Francis Lacombe, Marta Libura, Agata Majchrzak, Luca Maurillo, Yishai Ofran, Jan Philippé, Adriana Pleșa, Claude Preudhomme, Farhad Ravandi, Christophe Roumier, Marion Subklewe, Felicitas Thol, Arjan A. van de Loosdrecht, Bert A. van der Reijden, Adriano Venditti, Agnieszka Wierzbowska, Peter J.M. Valk, Brent L. Wood, Roland B. Walter, Christian Thiede, Konstanze Döhner, Gail J. Roboz, Jacqueline Cloos - Blood 2021 被引用: 718

  4. The DNA Inflammasome in Human Myeloid Cells Is Initiated by a STING-Cell Death Program Upstream of NLRP3

    著者: Moritz M. Gaidt, Thomas S. Ebert, Dhruv Chauhan, Katharina Ramshorn, Francesca Pinci, Sarah P Zuber, Fionan O’Duill, Jonathan L. Schmid‐Burgk, Florian Hoß, Raymund Buhmann, G. Wittmann, Eicke Latz, Marion Subklewe, Veit Hornung - Cell 2017 被引用: 649

  5. Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations

    著者: Kai Rejeski, Marion Subklewe, Mahmoud Aljurf, Emmanuel Bachy, Adriana Balduzzi, Pere Barba, Benedetto Bruno, Reuben Benjamin, Matteo Giovanni Carrabba, Christian Chabannon, Fabio Ciceri, Paolo Corradini, Julio Delgado, Roberta Di Blasi, Raffaella Greco, Roch Houot, Gloria Iacoboni, Ulrich Jäger, Marie José Kersten, Stephan Mielke, Arnon Nagler, Francesco Onida, Zinaida Perić, Claire Roddie, Annalisa Ruggeri, Fermín Sánchez‐Guijo, Isabel Sánchez‐Ortega, Dominik Schneidawind, Maria‐Luisa Schubert, John A. Snowden, Catherine Thiéblemont, Max S. Topp, Pier Luigi Zinzani, John G. Gribben, Chiara Bonini, Anna Sureda, Ibrahim Yakoub‐Agha - Blood 2023 被引用: 311

  6. CAR-HEMATOTOX: a model for CAR T-cell–related hematologic toxicity in relapsed/refractory large B-cell lymphoma

    著者: Kai Rejeski, Ariel Perez Perez, Pierre Sesques, Eva Hoster, Carolina Berger, Liv Jentzsch, Dimitrios Mougiakakos, Lisa Frölich, Josephine Ackermann, Veit Bücklein, Viktoria Blumenberg, Christian Schmidt, Laurent Jallades, Boris Fehse, Christoph Faul, Philipp Karschnia, Oliver Weigert, Martin Dreyling, Frederick L. Locke, Michael von Bergwelt‐Baildon, Andréas Mackensen, Wolfgang Bethge, Francis Ayuk, Emmanuel Bachy, Gilles Salles, Michael D. Jain, Marion Subklewe - Blood 2021 被引用: 441

  7. Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)

    著者: Patrick Hayden, Claire Roddie, Peter Bader, Grzegorz Basak, Halvard Bönig, Chiara Bonini, Christian Chabannon, Fabio Ciceri, Selim Corbacioglu, Rose Ellard, Fermín Sánchez‐Guijo, Ulrich Jäger, Michelle A.T. Hildebrandt, Michael Hudecek, Marie José Kersten, Ulrike Köhl, Jürgen Kuball, Stephan Mielke, Mohamad Mohty, John Murray, Arnon Nagler, Jeremy Rees, Catherine Rioufol, Riccardo Saccardi, John A. Snowden, Jan Styczyński, Marion Subklewe, Catherine Thiéblemont, Max S. Topp, A Urbano Ispizua, D. Chen, Radovan Vrḫovac, John G. Gribben, Nicolaus Kröger, Hermann Einsele, Ibrahim Yakoub‐Agha - Annals of Oncology 2021 被引用: 422

  8. A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy

    著者: Christoph K. Stein‐Thoeringer, Neeraj Saini, Eli Zamir, Viktoria Blumenberg, Maria‐Luisa Schubert, Uria Mor, Matthias Fante, Sabine Schmidt, Eiko Hayase, Tomo Hayase, Roman Rohrbach, Chia‐Chi Chang, Lauren McDaniel, Ivonne I. Flores, Rogier Gaiser, Matthias Edinger, Daniel Wolff, Martin Heidenreich, Paolo Strati, Ranjit Nair, Dai Chihara, Luis Fayad, Sairah Ahmed, Swaminathan P. Iyer, Raphaël Steiner, Preetesh Jain, Loretta J. Nastoupil, Jason R. Westin, Reetakshi Arora, Michael Wang, Joel G. Turner, Meghan Menges, Melanie J. Hidalgo-Vargas, Kayla Reid, Peter Dreger, Anita Schmitt, Carsten Müller‐Tidow, Frederick L. Locke, Marco L. Davila, Richard E. Champlin, Christopher R. Flowers, Elizabeth J. Shpall, Hendrik Poeck, Sattva S. Neelapu, Michael Schmitt, Marion Subklewe, Michael D. Jain, Robert R. Jenq, Eran Elinav - Nature Medicine 2023 被引用: 226

  9. T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals

    著者: Nora Philipp, Maryam Kazerani, Alyssa Nicholls, Binje Vick, Jan Wulf, Tobias Straub, Michaela Scheurer, Amelie Muth, Gerulf Hänel, Daniel Nixdorf, Monika Sponheimer, Malte Ohlmeyer, Sonja M. Lacher, Bettina Brauchle, Anetta Marcinek, Lisa Rohrbacher, Alexandra Leutbecher, Kai Rejeski, Oliver Weigert, Michael von Bergwelt‐Baildon, Sebastian Theurich, Roman Kischel, Irmela Jeremias, Veit Bücklein, Marion Subklewe - Blood 2022 被引用: 245

  10. A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy

    著者: David M. Cordas dos Santos, Tobias Tix, Roni Shouval, Anat Gafter‐Gvili, Jean-Baptiste Alberge, Edward R. Scheffer Cliff, Sebastian Theurich, Michael von Bergwelt‐Baildon, Irene M. Ghobrial, Marion Subklewe, Miguel‐Angel Perales, Kai Rejeski - Nature Medicine 2024 被引用: 246

  11. The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL

    著者: Kai Rejeski, Ariel Perez Perez, Gloria Iacoboni, Olaf Penack, Veit Bücklein, Liv Jentzsch, Dimitrios Mougiakakos, Grace Johnson, Brian Arciola, Cecilia Carpio, Viktoria Blumenberg, Eva Hoster, Lars Bullinger, Frederick L. Locke, Michael von Bergwelt‐Baildon, Andréas Mackensen, Wolfgang Bethge, Pere Barba, Michael D. Jain, Marion Subklewe - Journal for ImmunoTherapy of Cancer 2022 被引用: 191

  12. Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML

    著者: Sascha Haubner, Fabiana Perna, Thomas Köhnke, Christina Schmidt, Samuel Berman, Christian Augsberger, Frauke M. Schnorfeil, Christina Krupka, Felix S. Lichtenegger, X. Liu, Paul Kerbs, Stephanie Schneider, Klaus H. Metzeler, Karsten Spiekermann, Wolfgang Hiddemann, Philipp A. Greif, Tobias Herold, Michel Sadelain, Marion Subklewe - Leukemia 2018 被引用: 328

  13. GLA/DRST real-world outcome analysis of CAR-T cell therapies for large B-cell lymphoma in Germany

    著者: Wolfgang Bethge, Peter Martus, Michael Schmitt, Udo Holtick, Marion Subklewe, Bastian von Tresckow, Francis Ayuk, Eva Wagner-Drouet, Gerald Wulf, Reinhard Marks, Olaf Penack, Ulf Schnetzke, Christian Koenecke, Malte von Bonin, Matthias Stelljes, Bertram Glaß, Claudia D. Baldus, Vladan Vučinić, Dimitrios Mougiakakos, Max S. Topp, Matthias Fante, Roland Schroers, Lâle M. Bayir, Peter Borchmann, Veit Buecklein, Christine Hanoun, Simone Thomas, Dietrich W. Beelen, Claudia Lengerke, Nicolaus Kroeger, Peter Dreger - Blood 2022 被引用: 211

  14. T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments

    著者: Naval Daver, Ahmad S. Alotaibi, Veit Bücklein, Marion Subklewe - Leukemia 2021 被引用: 240

  15. Advances in cancer immunotherapy 2019 – latest trends

    著者: Stephan Krüger, Matthias Ilmer, Sebastian Kobold, Bruno L. Cadilha, Stefan Endres, Steffen Ormanns, Gesa Schuebbe, Bernhard W. Renz, Jan DʼHaese, Hans Anton Schloesser, Volker Heinemann, Marion Subklewe, Stefan Boeck, Jens Werner, Michael von Bergwelt‐Baildon - Journal of Experimental & Clinical Cancer Research 2019 被引用: 588

  16. Cooperative CAR targeting to selectively eliminate AML and minimize escape

    著者: Sascha Haubner, Jorge Mansilla‐Soto, Sarah Nataraj, Friederike Kogel, Qing Chang, Elisa de Stanchina, Michael Lopez, Mei Rosa Ng, Kathryn Fraser, Marion Subklewe, Jae H. Park, Xiuyan Wang, Isabelle Rivière, Michel Sadelain - Cancer Cell 2023 被引用: 107

  17. Structures of the human and Drosophila 80S ribosome

    著者: Andreas M. Anger, Jean‐Paul Armache, Otto Berninghausen, Michael Habeck, Marion Subklewe, Daniel N. Wilson, Roland Beckmann - Nature 2013 被引用: 659

  18. T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours

    著者: Stefanie Lesch, Viktoria Blumenberg, Stefan Stoiber, Adrian Gottschlich, Justyna Ogonek, Bruno L. Cadilha, Zahra Dantes, Felicitas Rataj, Klara Dorman, Johannes Lutz, Clara H. Karches, Constanze Heise, Mathias Kurzay, Benjamin M. Larimer, G Simon, Moritz Rapp, Alessia Nottebrock, Stephan Krüger, Nicholas Tokarew, Philipp Metzger, Christine Hoerth, Mohamed-Reda Benmebarek, Dario Dhoqina, Ruth Grünmeier, Matthias Seifert, Arman Oener, Öykü Umut, Sandy Joaquina, Lene Vimeux, Thi Tran, Thomas Hank, Taisuke Baba, Duc Huynh, Remco T. A. Megens, Klaus‐Peter Janssen, Martin Jastroch, Daniel Lamp, Svenja Ruehland, Mauro Di Pilato, Jasper N. Pruessmann, Moritz Thomas, Carsten Marr, Steffen Ormanns, Anna Reischer, Michael Hristov, Éric Tartour, Emmanuel Donnadieu, Simon Rothenfußer, Peter Duewell, Lars M. König, Max Schnurr, Marion Subklewe, Andrew S. Liss, Niels Halama, Maximilian Reichert, Thorsten R. Mempel, Stefan Endres, Sebastian Kobold - Nature Biomedical Engineering 2021 被引用: 175

  19. The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma

    著者: Kai Rejeski, Doris K. Hansen, Radhika Bansal, Pierre Sesques, Sikander Ailawadhi, Jennifer M. Logue, Eva Bräunlein, David M. Cordas dos Santos, Ciara L. Freeman, Melissa Alsina, Sebastian Theurich, Yucai Wang, Angela M. Krackhardt, Frederick L. Locke, Emmanuel Bachy, Michael D. Jain, Yi Lin, Marion Subklewe - Journal of Hematology & Oncology 2023 被引用: 117

  20. The BiTE (bispecific T‐cell engager) platform: Development and future potential of a targeted immuno‐oncology therapy across tumor types

    著者: Hermann Einsele, Hossein Borghaei, Robert Z. Orlowski, Marion Subklewe, Gail J. Roboz, Gerhard Zugmaier, Peter Kufer, Karim Iskander, Hagop M. Kantarjian - Cancer 2020 被引用: 231

  21. Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia

    著者: Adrian Gottschlich, Moritz Thomas, Ruth Grünmeier, Stefanie Lesch, Lisa Rohrbacher, Veronika Igl, Daria Briukhovetska, Mohamed-Reda Benmebarek, Binje Vick, Sertac Dede, K. Müller, Tao Xu, Dario Dhoqina, Florian Märkl, Sophie Robinson, Andrea Sendelhofert, Heiko Schulz, Öykü Umut, Vladyslav Kavaka, Christina Angeliki Tsiverioti, Emanuele Carlini, Sayantan Nandi, Thaddäus Strzalkowski, Theo Lorenzini, Sophia Stock, Philipp Jie Müller, Janina Dörr, Matthias Seifert, Bruno L. Cadilha, Ruben Brabenec, Natalie Röder, Felicitas Rataj, Manuel Nüesch, Franziska Modemann, Jasmin Wellbrock, Walter Fiedler, Christian Kellner, Eduardo Beltrán, Tobias Herold, Dominik Paquet, Irmela Jeremias, Louisa von Baumgarten, Stefan Endres, Marion Subklewe, Carsten Marr, Sebastian Kobold - Nature Biotechnology 2023 被引用: 111

  22. Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy

    著者: Gloria Iacoboni, Vı́ctor Navarro, Ana África Martín‐López, Kai Rejeski, Mi Kwon, Katarzyna Aleksandra Jalowiec, Paula Amat, Juan Luis Reguera, Laura Gallur, Viktoria Blumenberg, Sara Gutiérrez-Herrero, Claire Roddie, Ana Benzaquén, Javier Delgado‐Serrano, Mario Sánchez-Salinas, Rebeca Bailén, Cecilia Carpio, Lucía López‐Corral, Rafael Hernani, Mariana Bastos‐Oreiro, Maeve O’Reilly, Lourdes Martín‐Martín, Marion Subklewe, Pere Barba - Journal of Clinical Oncology 2023 被引用: 125

  23. Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion

    著者: Kai Rejeski, Ariel Perez Perez, Gloria Iacoboni, Viktoria Blumenberg, Veit Bücklein, Simon Völkl, Olaf Penack, Omar Albanyan, Sophia Stock, Fabian Müller, Philipp Karschnia, Agnese Petrera, Kayla Reid, Rawan Faramand, Marco L. Davila, Karnav Modi, Erin Dean, Christina A. Bachmeier, Michael von Bergwelt‐Baildon, Frederick L. Locke, Wolfgang Bethge, Lars Bullinger, Andréas Mackensen, Pere Barba, Michael D. Jain, Marion Subklewe - Science Advances 2023 被引用: 59

  24. Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality

    著者: Kai Rejeski, Yucai Wang, Doris K. Hansen, Gloria Iacoboni, Emmanuel Bachy, Radhika Bansal, Olaf Penack, Fabian Müller, Wolfgang Bethge, Javier Muñoz, Razan Mohty, Veit Bücklein, Pere Barba, Frederick L. Locke, Yi Lin, Michael D. Jain, Marion Subklewe - Blood Advances 2024 被引用: 69